Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Anti-Melanoma immunity and local regression of cutaneous metastases in melanoma patients treated with monobenzone and imiquimod; a phase 2 a trial
H.E. Teulings, Esther P.M. Tjin, Karina Willemsen, et al.
OncoImmunology (2018) Vol. 7, Iss. 4
Open Access | Times Cited: 36

Showing 1-25 of 36 citing articles:

Pharmacological modulation of nucleic acid sensors — therapeutic potential and persisting obstacles
Claire Vanpouille‐Box, Jules A. Hoffmann, Lorenzo Galluzzi
Nature Reviews Drug Discovery (2019) Vol. 18, Iss. 11, pp. 845-867
Closed Access | Times Cited: 149
Trial watch: Peptide-based vaccines in anticancer therapy
Lucillia Bezu, Oliver Kepp, Giulia Cerrato, et al.
OncoImmunology (2018) Vol. 7, Iss. 12, pp. e1511506-e1511506
Open Access | Times Cited: 144
The enigma and challenges of vitiligo pathophysiology and treatment
Zalfa Abdel‐Malek, Christian S. Jordan, Tina Ho, et al.
Pigment Cell & Melanoma Research (2020) Vol. 33, Iss. 6, pp. 778-787
Open Access | Times Cited: 89
Type I Interferon Production of Plasmacytoid Dendritic Cells under Control
Dóra Bencze, Tünde Fekete, Kitti Pázmándi
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 8, pp. 4190-4190
Open Access | Times Cited: 64
The Current State of Treatment and Future Directions in Cutaneous Malignant Melanoma
Madison Ernst, Alessio Giubellino
Biomedicines (2022) Vol. 10, Iss. 4, pp. 822-822
Open Access | Times Cited: 47
Immunology of Plasmacytoid Dendritic Cells in Solid Tumors: A Brief Review
Vladimír Koucký, J Bouček, Anna Fialová
Cancers (2019) Vol. 11, Iss. 4, pp. 470-470
Open Access | Times Cited: 65
The Role of Plasmacytoid Dendritic Cells in Cancers
Binhui Zhou, Toby Lawrence, Yinming Liang
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 54
The Diagnosis and Management of Cutaneous Metastases from Melanoma
Cosimo Di Raimondo, Flavia Lozzi, Pier Paolo Di Domenico, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 19, pp. 14535-14535
Open Access | Times Cited: 14
EMUDRA: Ensemble of Multiple Drug Repositioning Approaches to improve prediction accuracy
Xianxiao Zhou, Minghui Wang, Igor Katsyv, et al.
Bioinformatics (2018) Vol. 34, Iss. 18, pp. 3151-3159
Open Access | Times Cited: 42
Human Plasmacytoid Dendritic Cells and Cutaneous Melanoma
Matilde Monti, Francesca Consoli, Raffaella Vescovi, et al.
Cells (2020) Vol. 9, Iss. 2, pp. 417-417
Open Access | Times Cited: 33
Imiquimod Exerts Antitumor Effects by Inducing Immunogenic Cell Death and Is Enhanced by the Glycolytic Inhibitor 2-Deoxyglucose
Shi‐Wei Huang, Sin-Ting Wang, Shu-Hao Chang, et al.
Journal of Investigative Dermatology (2020) Vol. 140, Iss. 9, pp. 1771-1783.e6
Open Access | Times Cited: 31
The role of topical imiquimod in melanoma cutaneous metastases: A critical review of the literature
Federica Scarfì, Annalisa Patrizi, Giulia Veronesi, et al.
Dermatologic Therapy (2020) Vol. 33, Iss. 6
Open Access | Times Cited: 29
Clinical Approaches for the Management of Skin Cancer: A Review of Current Progress in Diagnosis, Treatment, and Prognosis for Patients with Melanoma
Christopher M. O Connor, Quinton L. Carr, Alisa Sweazy, et al.
Cancers (2025) Vol. 17, Iss. 4, pp. 707-707
Open Access
Plasmacytoid Dendritic Cell Impairment in Metastatic Melanoma by Lactic Acidosis
Matilde Monti, Raffaella Vescovi, Francesca Consoli, et al.
Cancers (2020) Vol. 12, Iss. 8, pp. 2085-2085
Open Access | Times Cited: 27
Impaired activation of plasmacytoid dendritic cells via toll-like receptor 7/9 and STING is mediated by melanoma-derived immunosuppressive cytokines and metabolic drift
Matilde Monti, Giorgia Ferrari, Valentina Grosso, et al.
Frontiers in Immunology (2024) Vol. 14
Open Access | Times Cited: 3
Inhibitory receptors of plasmacytoid dendritic cells as possible targets for checkpoint blockade in cancer
Laura Tiberio, Mattia Laffranchi, Giovanni Zucchi, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 3
Targeting the PD-1/PD-L1 Axis in Human Vitiligo
Marcella Willemsen, Cornelis J.M. Melief, Marcel W. Bekkenk, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 21
Melanoma and autoimmunity: spontaneous regressions as a possible model for new therapeutic approaches
Ion G. Motofei
Melanoma Research (2019) Vol. 29, Iss. 3, pp. 231-236
Closed Access | Times Cited: 21
Mechanism of action of 4‐substituted phenols to induce vitiligo and antimelanoma immunity
Arthur Kammeyer, Karin J. Willemsen, Wouter Ouwerkerk, et al.
Pigment Cell & Melanoma Research (2019) Vol. 32, Iss. 4, pp. 540-552
Open Access | Times Cited: 18
The Role of NKG2D in Vitiligo
Lourdes Plaza-Rojas, José A. Guevara-Patiño
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 15
Roles of Plasmacytoid Dendritic Cells in Gastric Cancer
Jinpu Yang, Xia Liu, Yiwen Cheng, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 11
The Role of TRL7/8 Agonists in Cancer Therapy, with Special Emphasis on Hematologic Malignancies
Maria Leśniak, Justyna Lipniarska, Patrycja Majka, et al.
Vaccines (2023) Vol. 11, Iss. 2, pp. 277-277
Open Access | Times Cited: 5
Optimization of Monobenzone-Induced Vitiligo Mouse Model by the Addition of Chronic Stress
Jing Dong, Yifan Lai, Xiaofeng Zhang, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 8, pp. 6990-6990
Open Access | Times Cited: 5
A chemical conjugation of JQ‐1 and a TLR7 agonist induces tumoricidal effects in a murine model of melanoma via enhanced immunomodulation
Xiaodong Wang, Bing-Ying Yu, Birong Cao, et al.
International Journal of Cancer (2020) Vol. 148, Iss. 2, pp. 437-447
Open Access | Times Cited: 14
The Multifaceted Functionality of Plasmacytoid Dendritic Cells in Gastrointestinal Cancers: A Potential Therapeutic Target?
Frederik J. Hansen, Paul David, Georg F. Weber
Cancers (2024) Vol. 16, Iss. 12, pp. 2216-2216
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top